These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1582285)

  • 1. Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome.
    Read CA; Clauw D; Weir C; Da Silva AT; Katz P
    Chest; 1992 May; 101(5):1282-6. PubMed ID: 1582285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion.
    Campagna AC; Blanc PD; Criswell LA; Clarke D; Sack KE; Gold WM; Golden JA
    Chest; 1992 May; 101(5):1274-81. PubMed ID: 1582284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis.
    Baydur A; Alsalek M; Louie SG; Sharma OP
    Chest; 2001 Jul; 120(1):102-8. PubMed ID: 11451823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease.
    Mahler DA; Harver A
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):467-70. PubMed ID: 1736759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary involvement in the eosinophilia-myalgia syndrome.
    Catton CK; Elmer JC; Whitehouse AC; Clode JB; Hustrulid RI
    Chest; 1991 Feb; 99(2):327-9. PubMed ID: 1989790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.
    Mahler DA; Faryniarz K; Tomlinson D; Colice GL; Robins AG; Olmstead EM; O'Connor GT
    Chest; 1992 Aug; 102(2):395-401. PubMed ID: 1643921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function studies in patients with prolapse of the mitral valve.
    ZuWallack R; Sinatra S; Lahiri B; Godar TJ; Liss JP; Jeresaty RM
    Chest; 1979 Jul; 76(1):17-20. PubMed ID: 446165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck manifestations of eosinophilia-myalgia syndrome.
    Levine B; Lanza DC; Ficco A; Freundlich B
    Ann Otol Rhinol Laryngol; 1995 Feb; 104(2):90-9. PubMed ID: 7857025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
    Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
    J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
    Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
    Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
    Marchman HB; Gleason CB; Shaw JC
    Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung volume, diffusing capacity, chest roentgenogram and dyspnea index in interstitial lung disease.
    Yang SC; Wu HD; Yang SP
    J Formos Med Assoc; 1991 Mar; 90(3):244-9. PubMed ID: 1677399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema.
    O'Donnell DE; Webb KA; Bertley JC; Chau LK; Conlan AA
    Chest; 1996 Jul; 110(1):18-27. PubMed ID: 8681624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
    Hudson JI; Pope HG; Carter WP; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report.
    Smith E; Gordon M; Lebwohl M
    Cutis; 2006 Jun; 77(6):361-4. PubMed ID: 16838769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated reduction in single-breath diffusing capacity in the evaluation of exertional dyspnea.
    Mohsenifar Z; Collier J; Belman MJ; Koerner SK
    Chest; 1992 Apr; 101(4):965-9. PubMed ID: 1555470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
    Hatch DL; Goldman LR
    Arch Intern Med; 1993 Oct; 153(20):2368-73. PubMed ID: 8215741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function and dyspnea in patients with permanent atrial fibrillation.
    Ariansen I; Edvardsen E; Borchsenius F; Abdelnoor M; Tveit A; Gjesdal K
    Eur J Intern Med; 2011 Oct; 22(5):466-70. PubMed ID: 21925054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data.
    Barth H; Berg PA; Klein R
    Adv Exp Med Biol; 1999; 467():487-96. PubMed ID: 10721092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.